SciELO - Scientific Electronic Library Online

 
vol.69 número3Diagnostic performance of platelet count/spleen diameter ratio to detect esophageal varices in patients with cirrhosisFactors associated with academic performance in undergraduate health sciences students enrolled in the human anatomy course índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista de la Facultad de Medicina

versão impressa ISSN 0120-0011

Resumo

GARZON, Carolina et al. Effect of neural therapy on NGF and BDNF serum levels in patients with chronic pain. A pilot study. rev.fac.med. [online]. 2021, vol.69, n.3, e203.  Epub 22-Out-2021. ISSN 0120-0011.  https://doi.org/10.15446/revfacmed.v69n3.80142.

Introduction:

Neurotrophins (NT) are a family of proteins consisting of the nerve growth factor (NGF), the brain-derived neurotrophic factor (BDNF) and NT-3 and NT-4/5. These proteins play an essential role in neuronal survival, differentiation, and proliferation.

Objectives:

To analyze the variations of NGF and BDNF serum levels in patients with chronic pain after undergoing neural therapy and to establish the effects of this type of intervention on their quality of life.

Materials and methods:

Prospective pilot study conducted in 10 patients with chronic pain treated with neural therapy between July 2017 and April 2018 in Bogotá D.C., Colombia. Three consultations were performed (one in which the intervention was initiated, and two follow-up visits every three weeks). During each consultation, the patients' quality of life was assessed using the SF-12 scale and their NGF and BDNF serum levels were measured. Data were analyzed by means of descriptive statistics, using medians and interquartile ranges for quantitative variables, and absolute frequencies and percentages for qualitative variables.

Results:

The median score on the SF-12 scale tended to improve in the first and second follow-up visits compared with the baseline score (pre-intervention), particularly during the first follow-up visit (consultation No. 1: 34.5; follow-up No. 1: 39.5, and follow-up No. 2: 38). Median NGF serum levels had a downward trend after the intervention, particularly in the first follow-up visit (157.6, 42.95, and 237.8, respectively), and in the case of BNDF, an overall downward trend was also found (29.96, 19.24 and 20.43, respectively). An improvement in quality of life related to the decrease in the serum levels of both neurotrophins was observed.

Conclusion:

Neural therapy intervention reduced NGF and BDNF serum levels and improved the quality of life of the participants. Therefore, the behavior of these neurotrophins could become a biomarker for the diagnosis, treatment, and follow-up of patients with chronic pain.

Palavras-chave : Nerve Growth Factors; Pain Management; Local Anesthetics; Quality of Life; Pain (MeSH).

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )